A new guideline from Kidney Disease: Improving Global Outcomes (KDIGO) updates recommendations on the management of antineutrophilic cytoplasmic antibody (ANCA)–associated vasculitis (AAV) to address ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. SAN DIEGO — Approximately two-thirds of patients with ...
Despite the frequency of coronary artery calcification among patients with antineutrophil cytoplasmic antibody-associated vasculitis, only 25% were using statins. A significant percentage of patients ...
Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis is a severe condition encompassing two major syndromes: granulomatosis with polyangiitis (formerly known as Wegener's granulomatosis) ...
Physicians presented the case of a patient with hypertensive emergency diagnosed as ANCA-associated vasculitis. The presence of a hypertensive emergency may be a sign of ANCA-associated vasculitis. In ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — In patients with ANCA-associated vasculitis, avacopan and rituximab may offer an alternative to ...
In patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis treated with rituximab, risk factors for relapse differed by treatment phase; musculoskeletal involvement was ...
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comes with a heavy quality-of-life burden that doesn't disappear after the early disease phase. This rare but heterogeneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results